MEDIcept Insights
New and Important Distributor Requirements Under EU MDR
European Union (EU) medical device regulations (EU MDR) have significantly increased the requirements for distributors. If you are currently a distributor of medical devices in the EU, or are considering doing so, it is important that you understand these new...
Coronary, Peripheral, and Neurovascular Guidewires – Performance Tests and Recommended Labeling
In October 2019, FDA released a guidance suggesting new labeling and performance testing relative to 510(k) premarket notification submissions for coronary, peripheral, and neurovascular guidewires under the product codes DQX and MOF. According to FDA, these new...
New Unique Device Identifier Deadline Approaches
A Unique Device Identifier (UDI) is a numeric or alphanumeric code that is assigned to a medical device. These codes are entirely unique, designed as a method to easily identify and determine the use of devices sold in the United States and Europe. The purpose of a...
New FDA Guidelines Affect Labeling Consideration for Intravascular Devices with Lubricious Coatings
Since their introduction two decades ago, hydrophilic and hydrophobic coatings on intravascular devices such as catheters, wires, and delivery systems have proven highly popular for decreasing the frictional force when the devices are introduced into the vasculature....
Virtual Audit Planning
Virtual audits are our current situation; yes, it’s a bit out of our collective comfort zone, but it beats not performing audits at all during this time of uncertainty. Quality System compliance can still be assessed no matter the environment, with a few key changes...
FDA Refuse-to-Accept (RTA) Guidance
The Federal Food and Drug Administration has revised its refuse-to-accept (RTA) policy for 510(k) submissions to clarify its guidance after the agency noted that its staff was spending too much time drafting extensive letters requesting additional information needed...